Tuesday, April 15, 2008
Generics Dampen Cost Increases in Cancer Care
Yes, the price of treating cancer is rising steadily with the advent of expensive targeted drugs. But that rise has been checked, for now, by the arrival of generic versions of some widely used chemotherapy drugs. The average annual drug cost per cancer patient was $13,113 as of Jan. 1 of this year, up from $6,490 [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment